Incidental detection of synchronous primary tumours during staging workup for prostate cancer

Swiss Medical Weekly

Volumn 140, Issue 15-16, 2010, Pages 233-236

  Özsoy, Orhan ^a   Fiorettab, Gérald ^b   Aresa, Carmen ^a   Miralbella, Raymond ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b GENEVA CANCER REGISTRY   (Switzerland)

Author keywords

Incidental cancer; Kidney neoplasms; Prostate neoplasms; Synchronous second primary cancer; X ray computerised tomography

Indexed keywords

AGED; ARTICLE; BLADDER CANCER; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; INCIDENTAL FINDING; KIDNEY CANCER; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIMARY TUMOR; PROSTATE CANCER; PROSTATECTOMY; RECTUM CANCER; SECOND CANCER; SWITZERLAND;

EID: 77951609205     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Higgins JC, Fitzgerald JM. Evaluation of incidental renal and adrenal mass. Am Fam Physician. 2001;63:288-294, 299.
2. Mitchell TL, Pippin JJ, Devers SM, Kimball TE, Gibbons LW, Cooper LL, et al. Incidental detection of preclinical renal tumors with electron beam computed tomography: report of 26 consecutive operated patients. J Comput Assist Tomogr. 2000;24:843-845
3. Cunha ACA, Molles SR, Maroclo RR. Prostatic and renal synchronous neoplasms. Braz J Urol. 2001;27:370-372
4. Osca Garcia JM, Morera Martinez JF, Alfonso Gil R, Ctala Barcelo, Ruiz Cerda JL, Martinez Jabaloyas JF, et al.The risk of second primary neoplasm in prostatic cancer patients. Actas Urol Esp. 1993;17:574-578
5. Ravi R, Prahlad S. Incidentally detected renal cell carcinoma in patients with other cancers. Urol Int. 1994;53:230-233
6. Fenton JJ, Weiss NS. Screening computed tomography: will it result in overdiagnosis of renal carcinoma? Cancer. 2004;100:986-990
7. Russo P. Renal cell carcinoma: presentation, staging, and surgical treatment. Semin Oncol. 2000;27:160-176
8. Mathews D, Öz OK. Positron emission tomography in prostate and renal cell carcinoma. Curr Opin Urol. 2002;12:381-385
9. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal carcinoma. J Urol. 2001;166:1611-1623
10. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628-1631
11. Luciani LG, Gestari R, Tallarigo C. Incidental renal cell carcinoma - age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology. 2000;56:58-62.
12. Russo P. Localized renal cell carcinoma. Curr Treat Options Oncol. 2001;2:447-455
13. Ficarra V, Prayer-Galetti T, Novella G, Bratti E, Maffei N, Dal Bianco M, et al. Incidental detection beyond pathological factors as prognostic predictor of renal cell carcinoma. Eur Urol. 2003;43:663-669
14. Gudbjartsson T, Thoroddsen A, Petursdottir V. Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. Urology 2005;66(6):1186-1191
15. Schlomer B, Figenhau RS, Yan V, Venkatesh R, Bhayani SB. Pathological features of renal neoplasms classified by size and symptomatology. J Urol. 2006;176(4 Pt 1):1317-1320
16. Harada K, Sakai I, Ishimura T,Inoue TA,Hara I,Miyake H, et al. Clinical symptoms in localized renal cell carcinoma reflect its invasive potential: comparative study between incidentally detected and symptomatic diseases. Urol Oncol. 2006;24(3):201-206
17. Gimenez Bachs JM, Donate Moreno MJ, Salinas Sanchez AS, Lorenzo Romero JG, Segura Martin M, Hernandez Millàn IR, et al. Growing incidence in renal cell carcinoma.Actas Urol Esp. 2006;30(3):295-300.
18. Koyama K, Furukawa Y, Tanaka H. Multiple primary malignant neoplasms in urologic patients. Scand J Urol Nephrol. 1995;29:483-490
19. Barocas DA, Rabbani F, Scherr DS, Vaughan ED Jr. A populationbased study of renal cell carcinoma and prostate cancer in the same patients. BJU Int. 2006;97(1):3-6.
20. Abbas F, Hochberg D, Civantos F, Soloway M. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur Urol. 1996;30:322-326
21. Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol. 1989;141:1091-1094
22. Montie JE, Wood DP Jr, Pontes JE, Boyett JM, Levin HS. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer. 1989;63:381-385
23. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology. 2007;243(1):28-53.
24. Fütterer JJ, Barentsz J, Heijmijnk ST. Imaging modalities for prostate cancer. Expert Rev Anticancer Ther. 2009;9(7):923-937
25. Joniau S, Van Poppel H. Localized prostate cancer: can we better define who is at risk of unfavourable outcome? BJU Int. 2008;101(Suppl 2):5-10.
26. Parulekar WR, McKenzie M, Chi KN, Klotz L, Catton C, Brundage M, et al. Defining the optimal treatment strategy for localized prostate cancer patients: a survey of ongoing studies at the National Cancer Institute of Canada Clinical Trials Group. Curr Oncol. 2008;15(4): 179-184
27. Osman MM, Cohade C, Fishman EK, Wahl RL. Clinically significant incidental findings on the unenhanced CT portion of PET/CT studies: frequency in 250 patients. J Nucl Med. 2005;46(8):1352-1355
28. Blomqvist L, Torkzad MR. Whole-body imaging with MRI or PET/ CT. The future for single-modality imaging in oncology? JAMA. 2003;290:3248-3249
29. Shreve P, Chiao PC, Humes HD, Schweiger M, Gross MD. Carbon- 11-acetate PET imaging in renal disease. J Nucl Med. 1995;36: 1595-1601
30. Mattar K, Jewett MA. Watchful waiting for small renal masses. Curr Urol Rep. 2008;9(1):22-25